Cargando…
Population structure and pharmacogenomic risk stratification in the United States
BACKGROUND: Pharmacogenomic (PGx) variants mediate how individuals respond to medication, and response differences among racial/ethnic groups have been attributed to patterns of PGx diversity. We hypothesized that genetic ancestry (GA) would provide higher resolution for stratifying PGx risk, since...
Autores principales: | Nagar, Shashwat Deepali, Conley, Andrew B., Jordan, I. King |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557099/ https://www.ncbi.nlm.nih.gov/pubmed/33050895 http://dx.doi.org/10.1186/s12915-020-00875-4 |
Ejemplares similares
-
The Apportionment of Pharmacogenomic Variation: Race, Ethnicity, and Adverse Drug Reactions
por: Jordan, I. King, et al.
Publicado: (2022) -
Population Pharmacogenomics for Precision Public Health in Colombia
por: Nagar, Shashwat Deepali, et al.
Publicado: (2019) -
Comparing Genetic and Socioenvironmental Contributions to Ethnic Differences in C-Reactive Protein
por: Nagar, Shashwat Deepali, et al.
Publicado: (2021) -
Socioeconomic deprivation and genetic ancestry interact to modify type 2 diabetes ethnic disparities in the United Kingdom
por: Nagar, Shashwat Deepali, et al.
Publicado: (2021) -
Race, Ethnicity, and Pharmacogenomic Variation in the United States and the United Kingdom
por: Sharma, Shivam, et al.
Publicado: (2023)